Literature DB >> 1586887

Low-dose tamoxifen retinopathy.

T Chang1, J R Gonder, M R Ventresca.   

Abstract

A 68-year-old woman with metastatic breast carcinoma manifested bilateral tamoxifen-induced retinopathy after 9 years of low-dose therapy. Treatment with the drug was stopped, with partial resolution of the retinopathy and improvement in visual acuity over 2 1/2 years of follow-up.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1586887

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


  5 in total

Review 1.  The differential diagnosis of crystals in the retina.

Authors:  F Nadim; H Walid; J Adib
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  [Tamoxifen retinopathy: a case series of clinical and functional data].

Authors:  C Ritter; A B Renner; J Wachtlin; N E Bechrakis; L Krause
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

3.  Phase I trial of droloxifene in patients with metastatic breast cancer.

Authors:  A U Buzdar; S Kau; G N Hortobagyi; R L Theriault; D Booser; F A Holmes; R Walters; I H Krakoff
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  The goldfish as a model for studying neuroestrogen synthesis, localization, and action in the brain and visual system.

Authors:  G V Callard; A Kruger; M Betka
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

5.  Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography.

Authors:  Albert Caramoy; Paula Scholz; Sascha Fauser; Bernd Kirchhof
Journal:  GMS Ophthalmol Cases       Date:  2011-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.